Sign in
ATRX Stock Price, Chart, Stats & News
Adhera Therapeutics Inc
Save
Adhera Therapeutics Inc (ATRX) does not currently pay a dividend.
722
Market cap
–
Current P/E
–
Forward P/E
ATRX chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson’s disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018.
Similar securities
Based on sector and market capitalization
Report issue